Advanced Technologies in Extracellular Vesicle Biosensing: Platforms, Standardization, and Clinical Translation
Molecules · 09.01.2026 · 31 (2) · 227
DOI: 10.3390/molecules31020227 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 09.01.2026. Verfasst von Seong-Jun Choi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Chemical Engineering and Bioengineering, College of Art, Culture and Engineering, Kangwon National University, Chuncheon 24341, Republic …. Hauptthemen laut MEDLINE: Biosensing Techniques, Extracellular Vesicles. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Institute of Planning, Korea government.
Abstract (Originalsprache)
Recently, extracellular vesicles (EVs) have emerged as pivotal mediators of intercellular communication that reflect physiological homeostasis and pathological alterations. By encapsulating diverse biomolecules, including proteins, nucleic acids, and lipids, EVs mirror the molecular signatures of their parent cells, thereby positioning EV-based biosensing as a transformative platform for noninvasive diagnostics, prognostic prediction, and therapeutic monitoring. This review provides a comprehensive overview of the current state and clinical translation of EV biosensing technologies. Herein, we have discussed ongoing efforts toward standardization and analytical validation (e.g., MISEV2023 and EV-TRACK) and evaluated advances in sensing modalities such as surface plasmon resonance (SPR), electrochemical, fluorescence, and magnetic detection systems, which have significantly improved analytical performance in terms of sensitivity and specificity. Furthermore, we highlight recent developments in multiplexed and multiomics integration at the single-EV level and the application of machine learning to enhance diagnostic accuracy and interpret biological heterogeneity. The clinical relevance of EV biosensing has been explored across multiple disease domains, including oncology, neurology, and cardiometabolic and infectious diseases, with an emphasis on translational progress toward standardized, regulatory-compliant, and scalable platforms. Finally, this review identifies key challenges in manufacturing scale-up, quality control, and point-of-care deployment and proposes a unified framework to accelerate the adoption of EV biosensing as a cornerstone of next-generation precision diagnostics and personalized medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Chemical Engineering and Bioengineering, College of Art, Culture and Engineering, Kangwon National University, Chuncheon 24341, Republic of Korea.
- Department of Smart Health Science and Technology, College of Engineering, Kangwon National University, Chuncheon 24341, Republic of Korea.
- Institute of Fermentation of Brewing, Kangwon National University, Chuncheon 24341, Republic of Korea.
- Institute of Industrial Technology, Kangwon National University, Chuncheon 24341, Republic of Korea.
ORCID-Profile: Kwang Suk Lim, Suk-Jin Ha, Hyun-Ouk Kim
Förderung
- National Research Foundation of Korea
- Korea Institute of Planning
- Korea government
Zitieren
APA
Choi, S. J., Choi, J., Kim, J., Kim, S. H., Cho, H. G., Lim, M. Y., Chae, S., Lim, K. S., Ha, S. J., & Kim, H. O. (2026). Advanced Technologies in Extracellular Vesicle Biosensing: Platforms, Standardization, and Clinical Translation. Molecules, 31(2), 227. https://doi.org/10.3390/molecules31020227
Vancouver
Choi SJ, Choi J, Kim J, Kim SH, Cho HG, Lim MY, et al. Advanced Technologies in Extracellular Vesicle Biosensing: Platforms, Standardization, and Clinical Translation. Molecules. 2026;31(2):227. doi:10.3390/molecules31020227
BibTeX
@article{Choi2026,
author = {Choi, Seong-Jun and Choi, Jaewon and Kim, Jin and Kim, Si-Hoon and Cho, Hyung-Geun and Lim, Min-Yeong and Chae, Sehyun and Lim, Kwang Suk and Ha, Suk-Jin and Kim, Hyun-Ouk},
title = {Advanced Technologies in Extracellular Vesicle Biosensing: Platforms, Standardization, and Clinical Translation},
journal = {Molecules},
year = {2026},
volume = {31},
number = {2},
pages = {227},
doi = {10.3390/molecules31020227}
}
EUVIMED